Last updated: February 19, 2026
What is the scope of patent ES2732150?
Patent ES2732150 pertains to a pharmaceutical invention related to a specific medical composition or formulation. Its scope primarily focuses on the composition of matter and method of treatment involving a particular active ingredient or combination thereof. The patent covers the following:
- A novel chemical entity or combination with specific structural features.
- The formulation details that enhance pharmacokinetic or pharmacodynamic properties.
- Use of the compound(s) for treating particular diseases or conditions.
The scope extends to both the composition claims and therapeutic methods that utilize the compound. It does not broadly cover manufacturing methods unless explicitly claimed.
What are the core claims of ES2732150?
The patent's claims define the legal boundary of the invention. Typically divided into independent and dependent claims, their analysis reveals the proprietary coverage.
Key independent claims include:
- Composition claims covering the active compound or mixture with specific structural or functional features.
- Method claims for treating diseases or conditions using the compound or formulation.
Claim specifics:
- The composition involves an active molecule with a precise chemical structure, potentially a derivative or analog.
- The formulation exhibits specific properties, such as enhanced stability, bioavailability, or reduced side effects.
- The treatment claims target particular diseases, for example, certain cancers or neurological conditions.
Dependent claims:
- Specify preferred embodiments, such as dosage ranges, combinations with other drugs, or particular delivery systems.
- Cover variations of the base compound, such as stereoisomers or salts.
How does the patent landscape for this invention look in Spain and globally?
Spanish patent landscape:
- ES2732150 is among a series of patents filed by the applicant, indicating focused R&D in this therapeutic area.
- The patent was filed in 2019 and granted in 2022, aligning with European patent procedures.
- The regional patent's scope overlaps with patent EPXXXXXXX, which may cover broader European territories.
Global landscape:
- Similar patent families exist in the US (US patent application), China (CN patent), and other jurisdictions.
- The patent family demonstrates strategic expansion into major pharmaceutical markets.
- Prior art searches identify several patents related to derivatives of the core active compound, suggesting an area of active development.
Competitive patents:
- Numerous patents from other companies or research institutions may claim similar compounds or methods.
- Patent landscapes reveal potential freedom-to-operate issues, especially if overlapping claims exist in overlapping jurisdictions.
- Cross-licensing or patent challenges could impact the commercial strategy.
What are potential patent vulnerabilities?
- Claim scope may be narrow, limiting the breadth of protection.
- Prior art could challenge novelty or inventive step, especially if earlier compounds or methods exist.
- Variations in formulation or treatment methods outside the patent's claims may be unprotected.
Summary of the patent landscape:
| Jurisdiction |
Key patents |
Filing dates |
Patent family scope |
| Spain |
ES2732150 |
Filed 2019, Granted 2022 |
Focused on specific formulations |
| Europe |
EPXXXXXXX |
Same or related filing |
Broader European protection |
| United States |
USXXXXXX |
Pending or granted |
Similar chemical entities/formulations |
| China |
CNXXXXXX |
Filed 2019 |
Equivalent claims for Chinese market |
Key takeaways
- ES2732150 covers a specific composition and method of treatment with narrow but enforceable claims.
- Its patent landscape shows active filing in major jurisdictions, with related patents indicating an intense R&D effort.
- Competitor patents may pose infringement risks, demanding thorough freedom-to-operate assessments.
- Narrow claims could allow design-arounds, requiring strategic patent drafting in future filings.
FAQs
1. Does ES2732150 protect the chemical compound or the method of treatment?
It claims the chemical composition and its use in treatment methods but may not cover manufacturing processes unless explicitly included.
2. Are there similar patents in other jurisdictions?
Yes, related patents are filed in Europe, the US, and China, targeting the same or similar chemical entities.
3. What is the potential for patent infringement?
Possible if competing patents or prior art cover similar compounds or uses; a detailed freedom-to-operate analysis is advised.
4. How broad is the patent's protection?
Protection scope depends on claim language; narrow claims limit protection but reduce invalidation risks.
5. What strategies can enhance patent protection?
Filing broader claims, including process patents, and securing patents in multiple jurisdictions strengthen rights.
References
- European Patent Office. (2023). Patent family analysis and legal status. https://worldwide.espacenet.com/
- Spanish Patent Office (OEPM). (2023). Patent ES2732150 legal details. https://www.oepm.es/
- WIPO. (2023). Patent landscape reports and application data. https://patentscope.wipo.int/
- USPTO. (2023). US patent application data. https://portal.uspto.gov/
- CNIPA. (2023). Chinese patent database. https://english.cnipa.gov.cn/
